Salvage radiosurgery for brain metastases: Prognostic factors to consider in patient selection

International Journal of Radiation Oncology Biology Physics

Volumn 88, Issue 1, 2014, Pages 137-142

  Kurtz, Goldie ^a   Zadeh, Gelareh ^b   Gingras Hill, Geneviève ^a   Millar, Barbara Ann ^a   Laperriere, Normand J ^a   Bernstein, Mark ^b   Jiang, Haiyan ^a   Ménard, Cynthia ^a   Chung, Caroline ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CONFIDENCE INTERVAL; EXTRACRANIAL DISEASE; METHODS AND MATERIALS; PERFORMANCE STATUS; PROGNOSTIC FACTORS; PROGRESSION FREE SURVIVAL; RECURSIVE PARTITIONING ANALYSIS; STEREOTACTIC RADIOSURGERY;

BRAIN; DIAGNOSIS; PATIENT MONITORING; RADIOTHERAPY; REGRESSION ANALYSIS;

INTERACTIVE COMPUTER SYSTEMS;

CORTICOSTEROID;

ADULT; AGE; AGED; ARTICLE; BRAIN METASTASIS; CANCER CONTROL; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CONTRAST ENHANCEMENT; CORTICOSTEROID THERAPY; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION NECROSIS; RADIOSURGERY; RETROSPECTIVE STUDY; SALVAGE THERAPY; SYSTEMIC THERAPY;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRAIN NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOSURGERY; RETROSPECTIVE STUDIES; SALVAGE THERAPY;

EID: 84890502824     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.10.003     Document Type: Article

References (19)

1. D.W. Andrews, C.B. Scott, and P.W. Sperduto Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomised trial Lancet 363 2004 1665 1672
2. E. Tabouret, O. Chinot, and P. Metellus Recent trends in epidemiology of brain metastases: An overview Anticancer Res 32 2012 4655 4662
3. M.N. Tsao, D. Wades, and A. Wirth Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline Pract Radiat Oncol 2 2012 210 225
4. H. Aoyama, H. Shirato, and M. Tago Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: A randomized controlled trial JAMA 295 2006 2483 2491
5. M.N. Tsao, W. Xu, and A. Sahgal A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases Cancer 118 2012 2486 2493
6. M.P. Mehta, M.N. Tsao, and T.J. Whelan The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases Int J Radiat Oncol Biol Phys 63 2005 37 46
7. M. Ammirati, C.S. Cobbs, and M.E. Linskey The role of retreatment in the management of recurrent/progressive brain metastases: A systematic review and evidence-based clinical practice guideline J Neurooncol 96 2010 85 96
8. P.Y. Wen, D.R. Macdonald, and D.A. Reardon Updated response assessment criteria for high-grade gliomas: Response assessment in Neuro-Oncology Working Group J Clin Oncol 28 2010 1963 1972
9. R. Gray A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1988 1141 1154
10. J.P. Klein, and M.L. Moeschberger Survival Analysis: Techniques for Censored and Truncated Data 2nd ed. 2003 Springer New York
11. G. Minniti, E. Clarke, and G. Lanzetta Stereotactic radiosurgery for brain metastases: Analysis of outcome and risk of brain radionecrosis Radiat Oncol 6 2011 1 9
12. L. Gaspar, C. Scott, and M. Rotman Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials Int J Radiat Oncol Biol Phys 37 1997 745 751
13. P.W. Sperduto, N. Kased, and D. Roberge Summary report on the graded prognostic assessment: An accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases J Clin Oncol 30 2012 419 425
14. A.V. Tallet, D. Azria, and F. Barlesi Neurocognitive function impairment after whole brain radiotherapy for brain metastases: Actual assessment Radiat Oncol 7 2012 1 8
15. E.L. Chang, J.S. Wefel, and K.R. Hess Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: A randomised controlled trial Lancet Oncol 10 2009 1037 1044
16. R. Soffietti, M. Kocher, and U.M. Abacioglu A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole brain radiotherapy versus observation in patients with one to three brain metastasesf from solid tumors after surgical resection or radiosurgery: Quality of life results J Clin Oncol 31 2013 65 72
17. J.A. Caballero, P.K. Sneed, and K.R. Lamborn Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy Int J Radiat Oncol Biol Phys 83 2012 303 309
18. S.T. Chao, G.H. Barnett, and M.A. Vogelbaum Salvage stereotactic radiosurgery effectively treats recurrences from whole-brain radiation therapy Cancer 113 2008 2198 2204
19. E. Maranzano, F. Trippa, and M. Casale Reirradiation of brain metastases with radiosurgery Radiother Oncol 102 2012 192 197